» Articles » PMID: 30258764

3D Tissue Engineering, an Emerging Technique for Pharmaceutical Research

Overview
Publisher Elsevier
Specialty Pharmacology
Date 2018 Sep 28
PMID 30258764
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue engineering and the tissue engineering model have shown promise in improving methods of drug delivery, drug action, and drug discovery in pharmaceutical research for the attenuation of the central nervous system inflammatory response. Such inflammation contributes to the lack of regenerative ability of neural cells, as well as the temporary and permanent loss of function associated with neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and traumatic brain injury. This review is focused specifically on the recent advances in the tissue engineering model made by altering scaffold biophysical and biochemical properties for use in the treatment of neurodegenerative diseases. A portion of this article will also be spent on the review of recent progress made in extracellular matrix decellularization as a new and innovative scaffold for disease treatment.

Citing Articles

Targeted Cancer Therapy-on-A-Chip.

Abed H, Radha R, Anjum S, Paul V, AlSawaftah N, Pitt W Adv Healthc Mater. 2024; 13(29):e2400833.

PMID: 39101627 PMC: 11582519. DOI: 10.1002/adhm.202400833.


Immune-mediated disruption of the blood-brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets.

Jia P, Peng Q, Fan X, Zhang Y, Xu H, Li J CNS Neurosci Ther. 2024; 30(7):e14853.

PMID: 39034473 PMC: 11260770. DOI: 10.1111/cns.14853.


Development of 3D skin equivalents for application in photodynamic biostimulation therapy assays using curcumin nanocapsules.

Amantino C, do Amaral S, Aires-Fernandes M, Oliani S, Tedesco A, Primo F Heliyon. 2024; 10(12):e32808.

PMID: 38975186 PMC: 11226835. DOI: 10.1016/j.heliyon.2024.e32808.


Recent progresses in neural tissue engineering using topographic scaffolds.

Han S, Zhao X, Cheng L, Fan J Am J Stem Cells. 2024; 13(1):1-26.

PMID: 38505822 PMC: 10944707.


Phenotypic Screening of Prospective Analgesics Among FDA-Approved Compounds using an iPSC-Based Model of Acute and Chronic Inflammatory Nociception.

Black B, Ghazal R, Lojek N, Williams V, Rajput J, Lawson J Adv Sci (Weinh). 2024; 11(11):e2303724.

PMID: 38189546 PMC: 10953557. DOI: 10.1002/advs.202303724.


References
1.
Kim D, Martin D . Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials. 2006; 27(15):3031-7. DOI: 10.1016/j.biomaterials.2005.12.021. View

2.
Ricciotti E, FitzGerald G . Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011; 31(5):986-1000. PMC: 3081099. DOI: 10.1161/ATVBAHA.110.207449. View

3.
Hong K, Khwaja A, Liapi E, Torbenson M, Georgiades C, Geschwind J . New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res. 2006; 12(8):2563-7. DOI: 10.1158/1078-0432.CCR-05-2225. View

4.
Breslin S, ODriscoll L . Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today. 2012; 18(5-6):240-9. DOI: 10.1016/j.drudis.2012.10.003. View

5.
Nimmerjahn A, Kirchhoff F, Helmchen F . Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005; 308(5726):1314-8. DOI: 10.1126/science.1110647. View